GURUFOCUS.COM » STOCK LIST » Asia » China » SZSE » China National Accord Medicines Corp Ltd (SZSE:000028) » Definitions » Gross-Profit-to-Asset %
Switch to:

China National Accord Medicines (SZSE:000028) Gross-Profit-to-Asset %

: 18.86% (As of Mar. 2023)
View and export this data going back to 1993. Start your Free Trial

Gross-Profit-to-Asset % is calculated as Gross Profit divided by its average Total Assets over a certain period of time. China National Accord Medicines's annualized Gross Profit for the quarter that ended in Mar. 2023 was ¥8,533 Mil. China National Accord Medicines's average Total Assets over the quarter that ended in Mar. 2023 was ¥45,250 Mil. Therefore, China National Accord Medicines's annualized Gross-Profit-to-Asset % for the quarter that ended in Mar. 2023 was 18.86%.


China National Accord Medicines Gross-Profit-to-Asset % Historical Data

The historical data trend for China National Accord Medicines's Gross-Profit-to-Asset % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

China National Accord Medicines Annual Data
Trend Dec13 Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22
Gross-Profit-to-Asset %
Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 19.89 18.73 19.17 19.47 20.90

China National Accord Medicines Quarterly Data
Jun18 Sep18 Dec18 Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23
Gross-Profit-to-Asset % Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 17.56 19.97 17.84 23.56 18.86

Competitive Comparison

For the Medical Distribution subindustry, China National Accord Medicines's Gross-Profit-to-Asset %, along with its competitors' market caps and Gross-Profit-to-Asset % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

   

China National Accord Medicines Gross-Profit-to-Asset % Distribution

For the Medical Distribution industry and Healthcare sector, China National Accord Medicines's Gross-Profit-to-Asset % distribution charts can be found below:

* The bar in red indicates where China National Accord Medicines's Gross-Profit-to-Asset % falls in comparison to its industry or sector. The grey bar indicates the Gross-Profit-to-Asset %'s extreme value range as defined by GuruFocus.



China National Accord Medicines Gross-Profit-to-Asset % Calculation

China National Accord Medicines's annualized Gross-Profit-to-Asset % for the fiscal year that ended in Dec. 2022 is calculated as:

Gross-Profit-to-Asset %=Gross Profit (A: Dec. 2022 )/( (Total Assets (A: Dec. 2021 )+Total Assets (A: Dec. 2022 ))/ count )
=8926.211/( (42783.682+42615.761)/ 2 )
=8926.211/42699.7215
=20.90 %

China National Accord Medicines's annualized Gross-Profit-to-Asset % for the quarter that ended in Mar. 2023 is calculated as:

Gross-Profit-to-Asset %=Gross Profit (Q: Mar. 2023 )/( (Total Assets (Q: Dec. 2022 )+Total Assets (Q: Mar. 2023 ))/ count )
=8533.208/( (42615.761+47885.198)/ 2 )
=8533.208/45250.4795
=18.86 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

In the calculation of annual Gross-Profit-to-Asset %, the Gross Profit of the last fiscal year and the average total assets over the fiscal year are used. In calculating the quarterly data, the Gross Profit data used here is four times the quarterly (Mar. 2023) data. Gross-Profit-to-Asset % is displayed in the 30-year financial page.


China National Accord Medicines Gross-Profit-to-Asset % Related Terms

Thank you for viewing the detailed overview of China National Accord Medicines's Gross-Profit-to-Asset % provided by GuruFocus.com. Please click on the following links to see related term pages.


China National Accord Medicines (SZSE:000028) Business Description

China National Accord Medicines logo
Traded in Other Exchanges
Address
No. 15, Ba Gua Si 4th Road, Accord Pharmaceutical Building, Futian District, Guangdong Province, Shenzhen, CHN, 518029
China National Accord Medicines Corp Ltd develops and manufactures pharmaceuticals in China. The company engaged in the wholesale of Chinese patent drugs, traditional Chinese medicines, chemical medicine preparations, antibiotics, biochemical drugs and cerebrovascular system drugs. It operates through the following segments: The Head office segment engages in investing and managing the business; The Pharmaceutical Distribution segment engages in the distribution of medicine and pharmaceutical products to customers, including hospitals, other distributors, retail drug stores, and clinics, and Retail pharmacy segment, which is managing the operation of Guoda Pharmacy. It generates maximum revenue from the Pharmaceutical Distribution segment.

China National Accord Medicines (SZSE:000028) Headlines

No Headlines